34630 The mental health and psychosocial burden among patients living with vitiligo in the United States: Findings from the VALIANT study

Abstract

Vitiligo is a chronic autoimmune disease characterized by the destruction of melanocytes, resulting in pale or white patches of skin. The population-based Vitiligo and Life Impact Among International Communities (VALIANT) study sought to understand the impact and burden of vitiligo on patients’ quality of life (QoL) from the perspective of patients and physicians in 17 countries. Participants aged ≥18 years who self-reported a clinical vitiligo diagnosis were recruited via an online panel and were asked questions regarding their mental health, psychosocial burden, and behavior in professional and social situations.